Search

Your search keyword '"Członkowska A"' showing total 1,918 results

Search Constraints

Start Over You searched for: Author "Członkowska A" Remove constraint Author: "Członkowska A"
1,918 results on '"Członkowska A"'

Search Results

Catalog

Books, media, physical & digital resources

3. Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets

5. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial

6. Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study

7. Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

9. The International Stroke Trial database

10. Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' experiences and attitudes

11. Brain Magnetic Resonance Imaging in Wilson’s Disease—Significance and Practical Aspects—A Narrative Review

12. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission

14. Italici an Itali?

15. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers

17. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial

18. Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention

21. Escape from the battlefield and its immediate punishment in the oath of the Samnite Linen Legion (Liv. 10.38). Part 2

23. Does Wilson's disease determine specific personality traits? Analysis of patients with the neurological form of the disease.

26. Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease

27. Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial

29. Escape from the battlefield and its immediate punishment in the oath of the Samnite Linen Legion (Liv. 10.38). Part 1

32. Wilson disease

33. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

35. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study

36. D-Penicillamine-Induced Myasthenia Gravis—A Probable Complication of Wilson’s Disease Treatment—A Case Report and Systematic Review of the Literature

37. Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review

38. Seven decades of clinical experience with Wilson's disease: Report from the national reference centre in Poland.

40. The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data From 121 Surgically Treated Participants From the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

41. Blood Based Biomarkers of Central Nervous System Involvement in Wilson’s Disease

42. Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

44. Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

46. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial

47. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial

48. Brain Magnetic Resonance Imaging in Wilson's Disease—Significance and Practical Aspects—A Narrative Review.

49. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

50. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial